Here are the top fake news stories from the past week:
- Here’s my favorite fake news story of the week. The administration’s very own national intelligence chiefs testified before a Senate panel that current global threats are pretty much all in direct opposition to what president Trump has claimed. The following day, Trump tweeted that his intelligence people were all wrong and “should go back to school.” The day after that, he met with his officials and then talked with the press. “They said they were totally misquoted and totally taken out of context,” Trump said of his officials. “They said it was fake news.” Now, that’s simply not true. The intelligence chiefs testified in public before the Senate, captured by live television cameras. There were not misquoted and the news was far from fake. This is simply the latest example of Mr. Trump calling real, factual reporting “fake news” just because he doesn’t like it. Something is not fake if you don’t agree with it. Read CNN’s reporting here.
- Russia is at it again. Apparently lawyers for a Russian company indicted by the Mueller comissision leaked confidential discovery information in the trial in an attempt to discredit Mueller’s investigation. Not purely a fake news thing (more of a disinformation/propaganda campaign), but close enough to warrant attention. The Washington Post reports on it here.
- Poynter reports how fake news sites are getting around Facebook’s fact-checking system by simply changing their domain names. Case in point, notorious fake news purveyor YourNewsWire migrated its site and rebranded itself as News Bunch. This apparently was tricky enough to fool those geniuses at Facebook. Read more here.
- The Jerusalem Post reported that a small company named Accelerated Evolution Biotechnologies is working on a potential anti-cancer drug cocktail that has shown promising results. The story, which was picked up my numerous other (mainly conservative) outlets, claimed that the company will have a complete cure for cancer within the year; it also failed to note that the company has yet to perform tests in humans or in fact publish any of its data. In other words, it’s yet another “cure for cancer” fake news story, similar to those that have been circulating for decades. This type of fake medical news is particularly heinous, as it serves only to raise false hopes. Wired analyzed the situation here.